Business · 05/12/2005
FDA Announces Call for Data on New Dandruff Control Ingredient
The FDA is seeking safety and efficacy data on Climbazole, a potential new ingredient for over-the-counter dandruff treatments, as part of its ongoing review of OTC drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →